The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4-fluorophenyl)(7-methyl-3-(quinolin-2-yl)-4,5-dihydroisoxazolo[5,4-c]pyridin-6(7H)-yl)methanone ID: ALA4558106
PubChem CID: 145864511
Max Phase: Preclinical
Molecular Formula: C23H18FN3O2
Molecular Weight: 387.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC1c2onc(-c3ccc4ccccc4n3)c2CCN1C(=O)c1ccc(F)cc1
Standard InChI: InChI=1S/C23H18FN3O2/c1-14-22-18(12-13-27(14)23(28)16-6-9-17(24)10-7-16)21(26-29-22)20-11-8-15-4-2-3-5-19(15)25-20/h2-11,14H,12-13H2,1H3
Standard InChI Key: KGFXBWZIVFHWJW-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
15.9724 -9.3152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3829 -10.1323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3829 -9.3152 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6777 -8.9024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0918 -8.9086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7983 -9.3193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0942 -8.0914 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.7944 -10.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5000 -10.5481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2099 -10.1415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2097 -9.3201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5034 -8.9132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9170 -10.5513 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.0900 -10.5420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6777 -10.5368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9724 -10.1323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3698 -10.6780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7026 -11.4199 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5108 -11.3325 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5700 -10.5104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3191 -9.7341 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2326 -10.9551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0310 -11.1193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9741 -10.1755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5207 -9.5684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2679 -8.7936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4689 -8.6247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9232 -9.2367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1789 -10.0091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 16 1 0
1 4 1 0
15 2 1 0
2 3 1 0
3 4 1 0
3 5 1 0
5 6 1 0
5 7 2 0
6 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 6 1 0
10 13 1 0
2 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 15 1 0
17 20 1 0
20 21 2 0
21 25 1 0
24 22 1 0
22 23 2 0
23 20 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 24 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 387.41Molecular Weight (Monoisotopic): 387.1383AlogP: 4.79#Rotatable Bonds: 2Polar Surface Area: 59.23Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.46CX LogD: 4.46Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -1.12
References 1. Yamamoto K, Inuki S, Ohno H, Oishi S.. (2019) Scaffold hopping of fused piperidine-type NK3 receptor antagonists to reduce environmental impact., 27 (10): [PMID:30975505 ] [10.1016/j.bmc.2019.03.059 ]